The Convergent Procedure Continues to Meet the Challenges

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
The Convergent Procedure Continues to Meet the Challenges of Treating Persistent Atrial Fibrillation -- Multiple European Centers Report Consistent Long-Term Results

MORRISVILLE, N.C., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Four European centers performing the Convergent Procedure recently presented data that continues to highlight consistent long-term results in the treatment of persistent atrial fibrillation (AF). AF is the most common arrhythmia, estimated to affect 15 million people in the Western world, with an estimated 88% falling into the difficult-to-treat persistent AF population. All patients in the 4 studies had persistent AF, and one third to nearly one half of patients had failed previous endocardial catheter ablations.

The cumulative data included 161 patients who all had persistent AF, and each study was presented at one of 4 European society meetings: Heart Rhythm Congress UK, European Society of Cardiology, American Association for Thoracic Surgery, and International AF Symposium.

             
Author & Institution

 
Society
Meeting
 
N

 
% Persistent or
Longstanding
Persistent
Mean
AF
Duration
Mean Sinus
Rhythm at
Follow-Up
Monitoring

 
Dr. Nick Child
Guy's & St. Thomas'
London, UK
Heart Rhythm Congress UK
London, UK
19

 
100%

 
7.8 yrs

 
90% at 1 year

 
Holter

 
Dr. Dmitri Pajitnev
Kerckhoff Klinik
Bad Nauheim, Germany
European Society of Cardiology
Barcelona, Spain
28

 
100%

 
4.6 yrs

 
80% at 1 year

 
Reveal
24/7
 
Dr. Michael Zembala
Sileasian Center for Heart Diseases
Zabrze, Poland
American Association for Thoracic Surgery,
Toronto, Canada
54

 
100%

 
4.4 yrs

 
85% at 1 year

 
Holter
7-day
 
Dr. Borut Gersak
University Medical Center Ljubljana
Ljubljana, Slovenia
International AF Symposium
Orlando, Florida
60

 
100%

 
6.2 yrs

 
83% at 1 year

 
Reveal
24/7
 

"Our institution, Guy's and St. Thomas' Hospital in London, is the latest site to report Convergent Procedure outcomes, and the results are consistent with other European reported outcomes this year," said Dr. Nick Child, Cardiology Research Fellow, Guy's and St. Thomas' NHS Foundation Trust. "Our study focused on patients not deemed to be standalone catheter ablation candidates. Our Convergent Procedure results have been impressive in these persistent AF patients. Some of these patients were particularly difficult – with large left atrial volumes and up to 8-year histories of persistent AF – and the Convergent Procedure effectively met these challenges. Frankly, we were not expecting such strong results; yet 90% of patients were in sinus rhythm at one year."

The multidisciplinary Convergent Procedure is typically performed as a single procedure in the electrophysiology lab in the United States. Due to European reimbursement requirements, most of the European data presented has involved staging the procedure with the surgical portion performed in the OR, and six weeks later, the patient returns for the catheter procedure. The epicardial lesions are created first under direct endoscopic visualization by a surgeon, through a 2 cm incision in the abdomen, with no chest incisions or ports. The endocardial lesions created by an electrophysiologist ensure lesion set completeness, and specialized EP mapping and diagnostics provide the "checks and balances" to ensure a comprehensive approach.

"These 4 recent studies are consistent with earlier published physician results in both the U.S. and Europe, and demonstrate the increasing value of a multidisciplinary approach," stated John Funkhouser, President of nContact. "Interestingly, the data from the four European sites and the seven latest publications from American sites is almost equivalent, with 84% of patients in NSR at one year in Europe and 85% in the US. The combined European and U.S. studies represent more than 500 patients. The continued physician success using a standardized epicardial-endocardial ablation in these difficult patients furthers our commitment to leading the development of long-term, Arrhythmia Disease Management Programs."

About nContact, Inc.

nContact's mission is to transform the underserved arrhythmia market through the advancement of less invasive ablation alternatives for cardiac arrhythmias. The Company is conducting the CONVERGE IDE Clinical Trial, the first head-to-head superiority study to evaluate the Convergent Procedure to catheter ablation in persistent atrial fibrillation patients. The Company's lead technology, EPi-Sense® Coagulation System with VisiTrax®, has CE Mark approval in Europe for the coagulation of cardiac tissue in the treatment of atrial fibrillation and atrial flutter. The EPi-Sense Coagulation System with VisiTrax is indicated for endoscopic coagulation of cardiac tissue in the U.S. nContact was founded in 2005 and is headquartered in Morrisville, North Carolina, USA.

Media Contact: Kris McCulloch nContact, Inc. T (919) 655-1351

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 156

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
Unisys Opens Its 2027 Innovation Program Across India

Updated Category News Views 147

Talent pipelines rarely make the market’s pulse race, but they can expose whether a tech firm is still trying to build for the next turn. Unisys has opened registration for the 2027 Unisys Innovation Program, its eighteenth annual technical competition for engineering students in India. For a company selling cloud, AI, digital workplace, applications and enterprise...

Continue Reading
ISDN Holdings: Leading APAC Automation with Innovation

Updated Category News Views 81

Pioneering Automation Intelligence in APAC Not every day you hear a company quietly revolutionizing an entire industry's landscape—but ISDN Holdings Limited is one of those rare players. Recognized by Frost & Sullivan for its top-tier customer value leadership, ISDN is making waves across the Asia-Pacific's industrial scene with its integrated industrial automation...

Continue Reading
Scalefusion’s Platinum Win Sharpens Its Brand Story

Updated Category News Views 14

A Film Is Not a Balance Sheet A slick brand film cannot patch a leaky product, but it can make a complicated platform easier to remember. That is the sensible takeaway from Scalefusion’s Platinum Level win at the 2026 MarCom Awards for “One Platform. One Agent. We are Scalefusion.” The recognition is for creative execution, not commercial performance, and anybody...

Continue Reading
Three Deal Reviews Put Merger Terms Under Scrutiny

Updated Category News Views 88

Three proposed transactions just picked up the sort of legal glare boards hate seeing. A shareholder-rights firm, Halper Sadeh, said on November 18, 2026 that it is investigating whether the deals involving Greenland Energy, Rapid Micro Biosystems and Aytu BioPharma may involve federal securities-law violations or breaches of fiduciary duty. That is an allegation worth...

Continue Reading
My Home Delivery's Bold Move in Big & Bulky Sector

Updated Category News Views 194

Redefining Big & Bulky Deliveries with AI Let me tell you, the logistics world isn't for the timid, and My Home Delivery (MHD) is swinging for the fences with their latest tech platform. These folks are rolling out an AI-driven system that promises to turn the bulky goods market on its head. Imagine moving your brand new fridge or that king-size bed across town without...

Continue Reading
Exiger's CEO Honored for Military Support Excellence

Updated Category News Views 80

Recognizing Civilian and Military Leadership When you hear "recognition in the military sector," it isn't just a pat on the back. It's a whole parade of brass hats and high-flyers giving their nods. So, November 10th wasn't just any regular day—Brandon Daniels, CEO of Exiger, gets a shiny, prestigious Five-Star Award for his "extraordinary support" of our military...

Continue Reading
AMPERA Joins Berto to Power Future Energy Innovations

Updated Category News Views 172

The Power Play You Didn't See Coming AMPERA and Berto just made a move that could stir up some serious waves in the energy sector. They've inked a business combination deal set to push advanced energy technology to the forefront. With AMPERA's valuation clocking in at roughly $900 million, this partnership aims to bring cutting-edge power solutions from concept to market....

Continue Reading
OREF Opens $185,000 Research Grant Funding Cycle Today

Updated Category News Views 97

A hundred grand aimed at better graft science is not pocket change, but it is not a finished clinical program either. That distinction matters with the Orthopaedic Research and Education Foundation's newly opened $185,000 grant cycle. This is targeted, early-to-midstream research support: the sort of money that can produce usable data, sharpen a clinical question, and...

Continue Reading
Clorox Boosts Payout With Steady $1.25 Dividend

Updated Category News Views 165

Quarterly Dividends: A Clorox Tradition It seems you can't talk about Clorox (NYSE: CLX) without mentioning its steadfast dedication to shareholders. Once again, this 113-year-old stalwart is back on the map with its juicy quarterly dividend—$1.25 per share, to be precise. That's scheduled to hit your account by February 12, 2027, if you're on the books by the end of...

Continue Reading

Top 5 Most Recently Viewed Articles

Foresight Autonomous Holdings Reports 2024 Financial Outcomes

Updated Category News Views 231

Financial Overview of Foresight Autonomous Holdings Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) has recently disclosed its financial results for the fourth quarter and overall year of 2024. The company, known for its groundbreaking 3D perception systems, reported annual revenues of $436,000. By the end of the year, it held $7.2 million in cash and equivalents,...

Continue Reading
Imperial Metals Showcases Remarkable First Quarter Growth

Updated Category News Views 156

Imperial Metals Demonstrates Strong Performance in First Quarter Imperial Metals Corporation (TSX:III) has revealed its financial results for the first quarter of 2025, showcasing remarkable growth in production and revenue. The company aims to maintain a trajectory of operational efficiency and profitability, continuing its commitment to sustainable mining practices. Key...

Continue Reading
MOBILion Systems Redefines Mass Spectrometry in Proteomics

Updated Category News Views 144

A New Era for Mass-Spectrometry-Based Proteomics In a groundbreaking achievement, MOBILion Systems has demonstrated a remarkable technical milestone, fundamentally changing mass-spectrometry-based proteomics. The company's proof-of-concept for high-resolution ion mobility (HRIM) showcases its innovative PAMAF mode, setting a new standard for efficient and effective...

Continue Reading
Celebrating Excellence: FASTSIGNS Honors Top Vendors for 2024

Updated Category News Views 316

FASTSIGNS International Celebrates Outstanding Vendors Grimco and Spicers Recognized for Exceptional Supplier Relationship FASTSIGNS®, a leading name in custom signs and visual solutions, recently honored Grimco as the U.S. Vendor of the Year and Spicers as the Canadian Vendor of the Year during the 2025 FASTSIGNS International Convention. The event took place in a...

Continue Reading
Insights into Central Government's 2026 Borrowing Plans

Updated Category News Views 116

Overview of the Central Government's Borrowing Strategy The update regarding the central government's borrowing strategy for 2026 has been officially released, providing crucial insights into the planned financial activities for the period. This detailed plan outlines essential objectives and anticipated actions that aim to enhance the overall stability of the economy....

Continue Reading